Page 16 - Pharma Companies

Retail investors miss rally in Gland Pharma; stock up 118% over IPO price

At the time of its IPO, retail investors bid for only 24 per cent or 0.24 times of the shares set aside for them

More pharma firms should be allowed to make vaccine: Nitin Gadkari

Union Minister Nitin Gadkari on Tuesday suggested that more pharma companies should be allowed to make the COVID-19 vaccine in the country during the pandemic to scale up production.

Additional 45,000 vials of tocilizumab allocated to states: Gowda

Union Minister Sadananda Gowda on Tuesday said additional 45,000 vials of tocilizumab, used for treatment of Covid-19, have been allocated to states and union territories to meet the increased demand.

FabiFlu numero uno in Indian pharma market, show April sales data

With sales of Rs 352 crore in April, this brand alone accounted for over 2 per cent of the total domestic pharma market sales of Rs 15,662 crore

After just Rs 18,000 cr profits in a decade, Serum, Bharat Biotech may earn big with Covid

For both companies, the pandemic presents a once-in-a-lifetime opportunity to earn hundreds of crores of rupees that could be ploughed back to fund further research and capacity expansion

Pricing pressure in US market to impact margins of pharma companies

Lack of new launches due to inspection delays, intensifying competition key headwinds

Morepen Laboratories rallies 17% in two days on fundraising plans

Morepen Laboratories board approved the issue of up to 5 crore equity shares to Liquid Holdings, an entity belonging to the promoter group of the company, at a price of Rs 38 per equity share

Private sector looking to pool demand for Covid vaccines procurement

Private sector in India is looking to pool their demand for effective procurement of vaccines to ensure uninterrupted access to the lifesaving vaccines, healthcare and industry federations said

Prioritise country first, PM Modi tells Covid-19 vaccine makers

"He has asked the industry to prioritise deliveries to meet the country's needs first and then focus on global supplies," said a person in the know, who did not wish to be named.

Covid-19: Remdesivir output to be doubled to 7.4 mn doses by April-end

18 new sites get DCGI consent to make antiviral used for treating Covid-19

Covid-19 vaccination: Too early to say if booster dose needed, say experts

Pfizer CEO has said a 3rd booster shot likely within a year of vaccination

The supply side

Ramping up vaccine availability has become critical

Dr Reddy's to also use govt cold chain infra for Sputnik V distribution

The vaccine would be transported in frozen form by air and road

Dr Reddy's to submit more data on Covid-19 vaccine Sputnik V by July

Colour-coded doses will have two different antigens

The second wave: Pharma stocks make a comeback as Covid-19 cases rise

However, analysts say these stocks may not deliver bumper returns like last year

Covid-19 vaccine: Real-world data to decide commercial marketing approval

Two such vaccines are Covishield, made by the Serum Institute of India (SII), and Covaxin by Bharat Biotech

J&J in talks with Centre for trial of single-shot Covid-19 vaccine

Russia's Sputnik V is another contender to get approval from the Indian drug regulator

Govt asks drug makers to ramp up remdesivir production to full capacity

The government on Wednesday said that all seven manufacturers of remdesivir in the country have been asked to ramp up production to full capacity by next week.

Biocon partners with Libbs Farmaceutica to launch generic drugs in Brazil

Biotechnology major Biocon on Monday said its subsidiary has joined hands with Libbs Farmaceutica to launch generic drugs in Brazil, the world's sixth most populous country.

Status check of PLI schemes that aim to make India world's factory

Last year, the govt introduced a PLI scheme for mobile phones, electronic components, critical pharma drugs and medical devices, which saw huge traction among global as well as Indian manufacturers